April 27, 2015
FDA issues Letters of Support to CAMD for Alzheimer’s and Parkinson’s disease biomarkers
Related Posts
-
eCOA Clinic #1 | Bring Your Own Device (BYOD) -
Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O). -
C-Path’s Translational Therapeutics Accelerator and Celdara Medical Announce Pipeline-focused MOU -
Successfully Navigating the Valley of Death: the Importance of Accelerators in Drug Discovery and Development
-
C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development